Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-100832
Filing Date
2023-04-14
Accepted
2023-04-13 19:44:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d464203d424b5.htm 424B5 372251
2 GRAPHIC g464203g01d24.jpg GRAPHIC 35553
3 GRAPHIC g464203g42t60.jpg GRAPHIC 35431
  Complete submission text file 0001193125-23-100832.txt   459776
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271174 | Film No.: 23819469
SIC: 2834 Pharmaceutical Preparations